4th International Conference on
Ophthalmology & Vision Science
June 17–18, 2027 | Berlin, Germany
CPD Accredited
Berlin, Germany
Phone: +44 2045874848
WhatsApp: +44 7383507342

IOVS 2027

Home › Scientific Sessions › Ophthalmogenetics, Genomics and Gene Therapy
Ophthalmogenetics, Genomics and Gene Therapy

Genetic research is transforming our understanding of inherited and complex ocular diseases by identifying molecular mechanisms, disease-associated variants, and potential therapeutic targets. Advances in gene therapy are creating new possibilities for treating selected inherited retinal disorders and other genetic eye conditions. Current research encompasses gene replacement, gene editing, genome-based diagnostics, targeted delivery systems, and personalized therapeutic strategies. Genomic and molecular information may also support earlier diagnosis, disease classification, prognosis, and treatment selection. This session will explore the latest developments and translational approaches connecting genetic discoveries with innovative therapies and the future of precision ophthalmology.

  • Ocular Genomics
  • Gene Replacement
  • CRISPR & Gene Editing
  • Inherited Retinal Diseases
  • Precision Medicine

Related Sessions

Tags